HPV Vaccination Study in Postpartum Women
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- HPV
- Human Papilloma Virus
- Immunization
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Health Services Research
Participation Requirements
- Age
- Between 15 years and 45 years
- Gender
- Only males
Description
This is a pilot, non-inferiority clinical trial using historical controls. Participants will have whole blood drawn at 0 months, 6 months, and 7 months and receive the HPV vaccine at 0 months, 6 months, and 12 months. Each blood draw will consist of one 15mL red top tube to measure HPV serologies an...
This is a pilot, non-inferiority clinical trial using historical controls. Participants will have whole blood drawn at 0 months, 6 months, and 7 months and receive the HPV vaccine at 0 months, 6 months, and 12 months. Each blood draw will consist of one 15mL red top tube to measure HPV serologies and hormone levels. All blood samples collected will be analyzed at the end of the study.
Tracking Information
- NCT #
- NCT04274153
- Collaborators
- Merck Sharp & Dohme Corp.
- Investigators
- Principal Investigator: Jenell Coleman, MD Johns Hopkins University Principal Investigator: Chailee Moss, MD Johns Hopkins University Principal Investigator: Betty Chou, MD Johns Hopkins University
Get Well Soon